JP2005529102A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529102A5 JP2005529102A5 JP2003583372A JP2003583372A JP2005529102A5 JP 2005529102 A5 JP2005529102 A5 JP 2005529102A5 JP 2003583372 A JP2003583372 A JP 2003583372A JP 2003583372 A JP2003583372 A JP 2003583372A JP 2005529102 A5 JP2005529102 A5 JP 2005529102A5
- Authority
- JP
- Japan
- Prior art keywords
- aerosol
- formulation
- compound
- formulation according
- aerosol pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0207899.6 | 2002-04-05 | ||
| GBGB0207899.6A GB0207899D0 (en) | 2002-04-05 | 2002-04-05 | Formoterol and cielesonide aerosol formulations |
| PCT/US2003/010285 WO2003086349A1 (en) | 2002-04-05 | 2003-04-01 | Formoterol and ciclesonide aerosol formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005529102A JP2005529102A (ja) | 2005-09-29 |
| JP2005529102A5 true JP2005529102A5 (https=) | 2006-06-01 |
| JP5198716B2 JP5198716B2 (ja) | 2013-05-15 |
Family
ID=9934322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583372A Expired - Fee Related JP5198716B2 (ja) | 2002-04-05 | 2003-04-01 | フォルモテロールおよびシクレソニドのエアロゾル製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050207984A1 (https=) |
| EP (1) | EP1492500B1 (https=) |
| JP (1) | JP5198716B2 (https=) |
| AT (1) | ATE401056T1 (https=) |
| AU (1) | AU2003262146A1 (https=) |
| CA (1) | CA2481187A1 (https=) |
| DE (1) | DE60322200D1 (https=) |
| GB (1) | GB0207899D0 (https=) |
| WO (1) | WO2003086349A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2312844T3 (es) | 2002-12-12 | 2009-03-01 | Nycomed Gmbh | Medicamento de combinacion de r, r-formoterol y ciclesonida. |
| US20060293293A1 (en) * | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
| GB0312148D0 (en) | 2003-05-28 | 2003-07-02 | Aventis Pharma Ltd | Stabilized pharmaceutical products |
| EP1635845A1 (en) * | 2003-06-13 | 2006-03-22 | ALTANA Pharma AG | Formoterol and ciclesonide combination |
| GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
| DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| EP2512438B1 (en) * | 2009-12-16 | 2017-01-25 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
| US10004859B2 (en) | 2012-05-09 | 2018-06-26 | Boehringer Ingelheim International Gmbh | Atomizer |
| US20170189329A1 (en) | 2014-07-29 | 2017-07-06 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| CN109789107B (zh) * | 2016-09-29 | 2021-12-03 | 广东东阳光药业有限公司 | 药物组合物 |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11452474B1 (en) | 2021-04-14 | 2022-09-27 | Satio, Inc. | Dual lever dermal patch system |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| DE19541689A1 (de) * | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
| AP791A (en) * | 1995-04-14 | 1999-12-17 | Glaxo Wellcome Inc | Metered dose inhaler for albuterol. |
| US6054488A (en) * | 1996-06-11 | 2000-04-25 | 3M Innovative Properties Company | Medicinal aerosol formulations of formoterol |
| GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| DE19753301A1 (de) * | 1997-12-01 | 1999-06-02 | Basf Ag | Verfahren zur Herstellung von Lactamen |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| CN1161104C (zh) * | 1998-06-18 | 2004-08-11 | 贝林格尔·英格海姆药物公司 | 有二种或多种活性物质的气溶胶药物制剂 |
| US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
| CN1150890C (zh) * | 1998-08-04 | 2004-05-26 | 杰格研究股份公司 | 药用气溶胶制剂 |
| US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| NZ522672A (en) * | 2000-05-23 | 2004-07-30 | Glaxo Group Ltd | Aerosol container for formulations of salmeterol xinafoate and preparation process thereof |
-
2002
- 2002-04-05 GB GBGB0207899.6A patent/GB0207899D0/en not_active Ceased
-
2003
- 2003-04-01 WO PCT/US2003/010285 patent/WO2003086349A1/en not_active Ceased
- 2003-04-01 US US10/510,147 patent/US20050207984A1/en not_active Abandoned
- 2003-04-01 AU AU2003262146A patent/AU2003262146A1/en not_active Abandoned
- 2003-04-01 DE DE60322200T patent/DE60322200D1/de not_active Expired - Lifetime
- 2003-04-01 CA CA002481187A patent/CA2481187A1/en not_active Abandoned
- 2003-04-01 JP JP2003583372A patent/JP5198716B2/ja not_active Expired - Fee Related
- 2003-04-01 AT AT03746589T patent/ATE401056T1/de not_active IP Right Cessation
- 2003-04-01 EP EP03746589A patent/EP1492500B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005529102A5 (https=) | ||
| US7273603B2 (en) | HFC solution formulations containing an anticholinergic | |
| ES2325316T3 (es) | Composiciones farmaceuticas para el tratamiento del asma. | |
| JP7836853B2 (ja) | Ｈｆａ－１３４ａ中のｒｐｌ５５４を含む吸入による投与用医薬組成物 | |
| ES2391563T5 (es) | Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor | |
| JP2001526685A (ja) | 薬用エアゾール製品 | |
| HU230804B1 (hu) | Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére | |
| JP2010505873A5 (ja) | 化合物、会合複合体、及び会合複合体を形成する方法 | |
| JP2004521134A5 (https=) | ||
| DE60322200D1 (de) | Formoterol und ciclesonid aerosol-formulierungen | |
| JP2005522421A5 (https=) | ||
| EP1471884A1 (en) | Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier | |
| FR2843882A1 (fr) | Formulation pharmaceutique de propionate de fluticasone | |
| JP2009541387A5 (https=) | ||
| PL196269B1 (pl) | Preparat aerozolowy roztworu, dostosowany do zastosowania w ciśnieniowym pojemniku aerozolowym, zawierający budesonid, wodorofluoroalkan i współrozpuszczalnik | |
| WO2008053250A3 (en) | Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser | |
| HUP0302036A2 (hu) | Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére | |
| JP2003530352A (ja) | サルメテロール及びイプラトロピウムを含む医薬組成物 | |
| TW200913984A (en) | Acetamide stereoisomer | |
| JP2013518061A5 (https=) | ||
| JP2016517435A5 (ja) | メロペネム誘導体及びその製造法 | |
| JP2005501082A5 (https=) | ||
| JP6815109B2 (ja) | デュロキセチンまたは薬学的に許容されるその塩を有効成分とする医薬組成物 | |
| JP2004525920A5 (https=) | ||
| JP2002212063A5 (https=) |